Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	inner ear receptor cell differentiation	CDH23 MYO3A OTOGL FGFR3 STRC USH2A STRCP1	2.78e-06	96	132	7	GO:0060113
GeneOntologyBiologicalProcess	inner ear auditory receptor cell differentiation	CDH23 MYO3A FGFR3 STRC USH2A STRCP1	4.44e-06	67	132	6	GO:0042491
GeneOntologyBiologicalProcess	mechanoreceptor differentiation	CDH23 MYO3A OTOGL FGFR3 STRC USH2A STRCP1	4.75e-06	104	132	7	GO:0042490
GeneOntologyBiologicalProcess	hair cell differentiation	CDH23 MYO3A FGFR3 STRC USH2A STRCP1	1.08e-05	78	132	6	GO:0035315
GeneOntologyBiologicalProcess	auditory receptor cell stereocilium organization	CDH23 MYO3A STRC STRCP1	2.15e-05	26	132	4	GO:0060088
GeneOntologyBiologicalProcess	inner ear receptor cell stereocilium organization	CDH23 MYO3A OTOGL STRC STRCP1	2.23e-05	53	132	5	GO:0060122
GeneOntologyBiologicalProcess	auditory receptor cell morphogenesis	CDH23 MYO3A STRC STRCP1	4.41e-05	31	132	4	GO:0002093
GeneOntologyBiologicalProcess	inner ear receptor cell development	CDH23 MYO3A OTOGL STRC STRCP1	1.05e-04	73	132	5	GO:0060119
GeneOntologyBiologicalProcess	auditory receptor cell development	CDH23 MYO3A STRC STRCP1	1.23e-04	40	132	4	GO:0060117
GeneOntologyCellularComponent	stereocilium tip	CDH23 MYO3A STRC STRCP1	1.05e-05	22	133	4	GO:0032426
GeneOntologyCellularComponent	stereocilium	CDH23 MYO3A STRC USH2A STRCP1	7.84e-05	69	133	5	GO:0032420
GeneOntologyCellularComponent	9+2 non-motile cilium	CDH23 STRC STRCP1	8.71e-05	14	133	3	GO:0097732
GeneOntologyCellularComponent	kinocilium	CDH23 STRC STRCP1	8.71e-05	14	133	3	GO:0060091
GeneOntologyCellularComponent	stereocilium bundle	CDH23 MYO3A STRC USH2A STRCP1	1.49e-04	79	133	5	GO:0032421
GeneOntologyCellularComponent	actin-based cell projection	ERBB2 CDH23 NLGN1 MYO3A STRC USH2A HYAL2 STRCP1	4.13e-04	278	133	8	GO:0098858
GeneOntologyCellularComponent	protein complex involved in cell adhesion	NLGN1 ITGAE ITGB6 NID1	5.44e-04	59	133	4	GO:0098636
GeneOntologyCellularComponent	cluster of actin-based cell projections	CDH23 MYO3A SHANK2 NPC1L1 STRC USH2A STRCP1	5.71e-04	223	133	7	GO:0098862
GeneOntologyCellularComponent	collagen-containing extracellular matrix	NPHS1 FN1 PF4V1 ZP2 HMCN2 HPX ADAMTS17 NID1 LTBP2 USH2A CDON	5.85e-04	530	133	11	GO:0062023
GeneOntologyCellularComponent	extracellular matrix	NPHS1 FN1 PF4V1 ZP2 HMCN2 OTOGL HPX ADAMTS17 NID1 LTBP2 USH2A CDON	9.98e-04	656	133	12	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	NPHS1 FN1 PF4V1 ZP2 HMCN2 OTOGL HPX ADAMTS17 NID1 LTBP2 USH2A CDON	1.02e-03	658	133	12	GO:0030312
GeneOntologyCellularComponent	basement membrane	NPHS1 FN1 HMCN2 NID1 USH2A	1.11e-03	122	133	5	GO:0005604
GeneOntologyCellularComponent	calcium channel complex	CACNA1B CATSPERD RYR2 PKD1	1.21e-03	73	133	4	GO:0034704
GeneOntologyCellularComponent	photoreceptor inner segment	CDH23 MYO3A SHANK2 USH2A	1.55e-03	78	133	4	GO:0001917
Domain	Clathrin_b-adaptin_app_Ig-like	AP1B1 AP2B1	4.73e-05	2	129	2	IPR013037
Domain	-	AP1B1 AP2B1	4.73e-05	2	129	2	2.60.40.1150
Domain	EGF_1	FN1 PGAP6 ITGB6 FAT2 HMCN2 NID1 LTBP2 USH2A HYAL2	7.06e-05	255	129	9	PS00022
Domain	Clathrin/coatomer_adapt-like_N	COPB1 AP1B1 AP2B1	1.38e-04	15	129	3	IPR002553
Domain	Adaptin_N	COPB1 AP1B1 AP2B1	1.38e-04	15	129	3	PF01602
Domain	AP_complex_bsu_1_2_4	AP1B1 AP2B1	1.41e-04	3	129	2	IPR016342
Domain	B2-adapt-app_C	AP1B1 AP2B1	1.41e-04	3	129	2	PF09066
Domain	G2F	HMCN2 NID1	2.81e-04	4	129	2	PF07474
Domain	B2-adapt-app_C	AP1B1 AP2B1	2.81e-04	4	129	2	SM01020
Domain	NIDOGEN_G2	HMCN2 NID1	2.81e-04	4	129	2	PS50993
Domain	GFP	HMCN2 NID1	2.81e-04	4	129	2	IPR009017
Domain	B-adaptin_app_sub_C	AP1B1 AP2B1	2.81e-04	4	129	2	IPR015151
Domain	G2_nidogen/fibulin_G2F	HMCN2 NID1	2.81e-04	4	129	2	IPR006605
Domain	EGF-like_CS	FN1 PGAP6 ITGB6 FAT2 HMCN2 NID1 LTBP2 HYAL2	4.65e-04	261	129	8	IPR013032
Domain	AP_beta	AP1B1 AP2B1	4.67e-04	5	129	2	IPR026739
Domain	Helical_ferredxn	DPYD CDON	4.67e-04	5	129	2	IPR009051
Domain	Beta2_adaptin/TBP_C_dom	AP1B1 AP2B1	6.97e-04	6	129	2	IPR012295
Domain	-	AP1B1 AP2B1	6.97e-04	6	129	2	3.30.310.10
Pubmed	Otogelin, otogelin-like, and stereocilin form links connecting outer hair cell stereocilia to each other and the tectorial membrane.	CDH23 OTOGL STRC STRCP1	7.44e-08	11	137	4	31776257
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	HK2 DOCK10 TARS2 ECT2 PIAS1 JMJD1C RPAP1 AP1B1 MID1 MLH1 CDK5RAP1 DHX34 TOP3A LRRC41	3.17e-07	650	137	14	38777146
Pubmed	An unusually powerful mode of low-frequency sound interference due to defective hair bundles of the auditory outer hair cells.	CDH23 STRC STRCP1	5.95e-07	5	137	3	24920589
Pubmed	Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane.	CDH23 STRC STRCP1	3.30e-06	8	137	3	21165971
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ERBB2 CHCHD5 ARHGAP26 GRIN2D FAAP100 IGF2R SHANK2 RPAP1 PKD1 COBL ULK4 PCNX1 DHX34 TRAPPC9 TOP3A ZNF687	7.84e-06	1105	137	16	35748872
Pubmed	Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers.	ERBB2 TRAPPC9	1.54e-05	2	137	2	23474757
Pubmed	Dual-vector gene therapy restores cochlear amplification and auditory sensitivity in a mouse model of DFNB16 hearing loss.	STRC STRCP1	1.54e-05	2	137	2	34910522
Pubmed	Overexpression of transforming growth factor β induced factor homeobox 1 represses NPC1L1 and lowers markers of intestinal cholesterol absorption.	TGIF1 NPC1L1	1.54e-05	2	137	2	29980051
Pubmed	Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells.	CDH23 USH2A	1.54e-05	2	137	2	17360538
Pubmed	αv-Class integrin binding to fibronectin is solely mediated by RGD and unaffected by an RGE mutation.	FN1 NID1	1.54e-05	2	137	2	33141174
Pubmed	Pecanex functions as a competitive endogenous RNA of S-phase kinase associated protein 2 in lung cancer.	SKP2 PCNX1	1.54e-05	2	137	2	28789966
Pubmed	Regional localization of the fibronectin and gamma crystallin genes to mouse chromosome 1 by in situ hybridization.	FN1 CRYGA	1.54e-05	2	137	2	3248380
Pubmed	Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus.	STRC STRCP1	1.54e-05	2	137	2	11687802
Pubmed	Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain.	ERBB2 FGFR3	1.54e-05	2	137	2	20713021
Pubmed	Differential Expression of HER2 and SKP2 in Benign and Malignant Colorectal Lesions.	ERBB2 SKP2	1.54e-05	2	137	2	32856866
Pubmed	Induction of fibronectin by HER2 overexpression triggers adhesion and invasion of breast cancer cells.	ERBB2 FN1	1.54e-05	2	137	2	25743092
Pubmed	Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus.	NPHS1 FN1 NID1	3.90e-05	17	137	3	18082680
Pubmed	Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics.	STRC STRCP1	4.61e-05	3	137	2	30801007
Pubmed	Interaction of the leucine-rich repeats of polycystin-1 with extracellular matrix proteins: possible role in cell proliferation.	FN1 PKD1	4.61e-05	3	137	2	11752017
Pubmed	Binding of MMP-9-degraded fibronectin to β6 integrin promotes invasion via the FAK-Src-related Erk1/2 and PI3K/Akt/Smad-1/5/8 pathways in breast cancer.	FN1 ITGB6	4.61e-05	3	137	2	26134759
Pubmed	Characterization of a gene trap insertion into a novel gene, cordon-bleu, expressed in axial structures of the gastrulating mouse embryo.	ERBB2 COBL	4.61e-05	3	137	2	7586755
Pubmed	Ethanol enhances the interaction of breast cancer cells over-expressing ErbB2 with fibronectin.	ERBB2 FN1	4.61e-05	3	137	2	20201928
Pubmed	FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.	ERBB2 SKP2	4.61e-05	3	137	2	18008005
Pubmed	Polycystin-1 is required for stereocilia structure but not for mechanotransduction in inner ear hair cells.	CDH23 PKD1	4.61e-05	3	137	2	21865467
Pubmed	Identification by shotgun sequencing, genomic organization, and functional analysis of a fourth arylsulfatase gene (ARSF) from the Xp22.3 region.	ARSL ARSF	4.61e-05	3	137	2	9192838
Pubmed	Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.	ERBB2 SKP2	4.61e-05	3	137	2	32989258
Pubmed	Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells.	ERBB2 FGFR3	4.61e-05	3	137	2	24909170
Pubmed	The adaptor function of TRAPPC2 in mammalian TRAPPs explains TRAPPC2-associated SEDT and TRAPPC9-associated congenital intellectual disability.	TRAPPC8 TRAPPC9	4.61e-05	3	137	2	21858081
Pubmed	Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer: Results of the Prospective Cologne Esophageal Response Prediction (CERP) Study.	DPYD ERBB2	4.61e-05	3	137	2	27741011
Pubmed	A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy.	ARSL ARSF	4.61e-05	3	137	2	7720070
Pubmed	The self-association and fibronectin-binding sites of fibulin-1 map to calcium-binding epidermal growth factor-like domains.	FN1 NID1	4.61e-05	3	137	2	9278415
Pubmed	An investigation into the human serum "interactome".	NPHS1 FN1 PF4V1 RYR2 ADRA1B HPX	4.63e-05	162	137	6	15174051
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	FN1 PF4V1 HMCN2 ADAMTS17 NID1 LTBP2	5.48e-05	167	137	6	22159717
Pubmed	Stereocilin-deficient mice reveal the origin of cochlear waveform distortions.	STRC STRCP1	9.19e-05	4	137	2	18849963
Pubmed	Homology models of human gamma-crystallins: structural study of the extensive charge network in gamma-crystallins.	CRYGA CRYGC	9.19e-05	4	137	2	12507494
Pubmed	A fibronectin-independent mechanism of collagen fibrillogenesis in adult liver remodeling.	FN1 ITGB6	9.19e-05	4	137	2	21320502
Pubmed	Alphavbeta6-Fyn signaling promotes oral cancer progression.	FN1 ITGB6	9.19e-05	4	137	2	12917446
Pubmed	Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis.	ERBB2 CDH23	9.19e-05	4	137	2	23592719
Pubmed	Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein.	FN1 ITGB6	9.19e-05	4	137	2	1532572
Pubmed	The physical and genetic map surrounding the Lyst gene on mouse chromosome 13.	RYR2 NID1	9.19e-05	4	137	2	9070932
Pubmed	Association of epidermal growth factor receptors with coated pit adaptins via a tyrosine phosphorylation-regulated mechanism.	AP1B1 AP2B1	9.19e-05	4	137	2	7534311
Pubmed	cDNA and genomic cloning of lacritin, a novel secretion enhancing factor from the human lacrimal gland.	FN1 NID1	9.19e-05	4	137	2	11419941
Pubmed	Accumulation of type IV collagen in dilated ER leads to apoptosis in Hsp47-knockout mouse embryos via induction of CHOP.	FN1 NID1	9.19e-05	4	137	2	15522896
Pubmed	Role of activation of PIP5Kgamma661 by AP-2 complex in synaptic vesicle endocytosis.	AP1B1 AP2B1	9.19e-05	4	137	2	17290217
Pubmed	Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.	ERBB2 PTGER1	9.19e-05	4	137	2	14744769
Pubmed	Cleavage of the Bloom's syndrome gene product during apoptosis by caspase-3 results in an impaired interaction with topoisomerase IIIalpha.	MLH1 TOP3A	9.19e-05	4	137	2	11470874
Pubmed	Weill-Marchesani Syndrome	ADAMTS17 LTBP2	9.19e-05	4	137	2	20301293
Pubmed	Differential regulation of gamma-crystallin genes during mouse lens development.	CRYGA CRYGC	9.19e-05	4	137	2	3792630
Pubmed	The mouse eye lens obsolescence (Elo) mutant: studies on crystallin gene expression and linkage analysis between the mutant locus and the gamma-crystallin genes.	CRYGA CRYGC	9.19e-05	4	137	2	3428594
Pubmed	Novel mutations in the gamma-crystallin genes cause autosomal dominant congenital cataracts.	CRYGA CRYGC	9.19e-05	4	137	2	12011157
Pubmed	Genetic and allelic heterogeneity of Cryg mutations in eight distinct forms of dominant cataract in the mouse.	CRYGA CRYGC	9.19e-05	4	137	2	15037589
Pubmed	Assignment of the human gamma-crystallin gene cluster (CRYG) to the long arm of chromosome 2, region q33-36.	CRYGA CRYGC	9.19e-05	4	137	2	3011643
Pubmed	Temporal regulation of six crystallin transcripts during mouse lens development.	CRYGA CRYGC	9.19e-05	4	137	2	1623964
Pubmed	ATM binds to beta-adaptin in cytoplasmic vesicles.	AP1B1 AP2B1	9.19e-05	4	137	2	9707615
Pubmed	Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.	MAPK8IP1 ERBB2 SKP2 IGF2R MAP3K10 FGFR3 TRAPPC9	1.17e-04	276	137	7	28319085
Pubmed	ZFP57 dictates allelic expression switch of target imprinted genes.	IGF2R COBL TRAPPC9	1.29e-04	25	137	3	33500348
Pubmed	The crystallins: genes, proteins and diseases.	CRYGA CRYGC	1.53e-04	5	137	2	9426193
Pubmed	Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1.	FN1 ITGB6	1.53e-04	5	137	2	16260650
Pubmed	Rif1 provides a new DNA-binding interface for the Bloom syndrome complex to maintain normal replication.	RIF1 TOP3A	1.53e-04	5	137	2	20711169
Pubmed	Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor.	FN1 ITGB6	1.53e-04	5	137	2	8120056
Pubmed	Structure of the crystallins.	CRYGA CRYGC	1.53e-04	5	137	2	10627816
Pubmed	The synaptic proteins neurexins and neuroligins are widely expressed in the vascular system and contribute to its functions.	NLGN1 F8	1.53e-04	5	137	2	19926856
Pubmed	Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan.	FN1 NID1	1.53e-04	5	137	2	11493006
Pubmed	Rad5 and Its Human Homologs, HLTF and SHPRH, Are Novel Interactors of Mismatch Repair.	SHPRH MLH1	1.53e-04	5	137	2	35784486
Pubmed	Endocytosis of the glucose transporter GLUT8 is mediated by interaction of a dileucine motif with the beta2-adaptin subunit of the AP-2 adaptor complex.	AP1B1 AP2B1	1.53e-04	5	137	2	16723738
Pubmed	Structure--function relationships in HIV-1 Nef.	COPB1 AP1B1 AP2B1	1.63e-04	27	137	3	11463741
Pubmed	Genetic link between renal birth defects and congenital heart disease.	AP1B1 AP2B1 PKD1	1.82e-04	28	137	3	27002738
Pubmed	Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996.	FN1 ITGB6 CRYGA CRYGC	1.82e-04	71	137	4	8751373
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	CACNA1B COPB1 DDX60 DOCK10 MID1 COBL	1.83e-04	208	137	6	33230847
Pubmed	Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism.	MIER2 DPYD ERBB2 LAX1 AP2B1 FGFR3 TRIM37 DNPEP	2.03e-04	402	137	8	24722188
Pubmed	Human gamma-crystallin genes. A gene family on its way to extinction.	CRYGA CRYGC	2.29e-04	6	137	2	2258929
Pubmed	Somatic mutation of epidermal growth factor receptor in a small subset of cutaneous squamous cell carcinoma.	ERBB2 FGFR3	2.29e-04	6	137	2	19812598
Pubmed	The type XIII collagen ectodomain is a 150-nm rod and capable of binding to fibronectin, nidogen-2, perlecan, and heparin.	FN1 NID1	2.29e-04	6	137	2	11956183
Pubmed	Clathrin.	AP1B1 AP2B1	2.29e-04	6	137	2	10966473
Pubmed	Podocyte-Specific Deletion of Murine CXADR Does Not Impair Podocyte Development, Function or Stress Response.	NPHS1 NID1	2.29e-04	6	137	2	26076477
Pubmed	Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.	PCNX1 CDON	2.29e-04	6	137	2	22881374
Pubmed	Gamma-crystallins of the human eye lens: expression analysis of five members of the gene family.	CRYGA CRYGC	2.29e-04	6	137	2	3670288
Pubmed	Similar subunit interactions contribute to assembly of clathrin adaptor complexes and COPI complex: analysis using yeast three-hybrid system.	COPB1 AP1B1	2.29e-04	6	137	2	11409905
Pubmed	p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.	ERBB2 SKP2	2.29e-04	6	137	2	16951165
Pubmed	Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.	ERBB2 FGFR3	2.29e-04	6	137	2	18231572
Pubmed	Semaphorin 3E/PlexinD1 signaling is required for cardiac ventricular compaction.	ERBB2 FN1 HYAL2	2.73e-04	32	137	3	31434798
Pubmed	The intracellular NADH level regulates atrophic nonunion pathogenesis through the CtBP2-p300-Runx2 transcriptional complex.	HK2 SKP2 TMC3 PGAP6 SLCO4C1	2.73e-04	144	137	5	30585266
Pubmed	Biochemical characterization of native Usher protein complexes from a vesicular subfraction of tracheal epithelial cells.	CDH23 USH2A	3.19e-04	7	137	2	20058854
Pubmed	A genome-wide association study of carotid atherosclerosis in HIV-infected men.	MAST4 AP1B1	3.19e-04	7	137	2	20009918
Pubmed	A flexible, multilayered protein scaffold maintains the slit in between glomerular podocytes.	NPHS1 NID1	3.19e-04	7	137	2	27430022
Pubmed	Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse).	FN1 NID1	3.19e-04	7	137	2	10716744
Pubmed	Mapping of mouse gamma crystallin genes on chromosome 1.	FN1 CRYGA	3.19e-04	7	137	2	3242494
Pubmed	Integrins are required for the differentiation of visceral endoderm.	FN1 NID1	3.19e-04	7	137	2	19118216
Pubmed	Interaction between the helicases genetically linked to Fanconi anemia group J and Bloom's syndrome.	MLH1 TOP3A	3.19e-04	7	137	2	21240188
Pubmed	alpha3beta1 Integrin is required for normal development of the epidermal basement membrane.	FN1 NID1	3.19e-04	7	137	2	9151677
Pubmed	Hepatic glycogen synthesis in the absence of glucokinase: the case of embryonic liver.	HK2 GYS1	3.19e-04	7	137	2	18165236
Pubmed	Characterization of a mouse gene (Fbxw6) that encodes a homologue of Caenorhabditis elegans SEL-10.	FBXW4 SKP2	3.19e-04	7	137	2	11735228
Pubmed	Differential effects of the integrins alpha9beta1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. Roles of the beta subunit extracellular and cytoplasmic domains.	FN1 ITGB6	3.19e-04	7	137	2	8798654
Pubmed	Ypt1 recruits the Atg1 kinase to the preautophagosomal structure.	TRAPPC8 TRAPPC9	3.19e-04	7	137	2	23716696
Pubmed	Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor.	ERBB2 AP2B1	3.19e-04	7	137	2	16314522
Pubmed	Sorting of growth plate chondrocytes allows the isolation and characterization of cells of a defined differentiation status.	IGF2R FGFR3	3.19e-04	7	137	2	20200945
Pubmed	Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin.	FN1 NID1	3.19e-04	7	137	2	9501082
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	ERBB2 TBC1D22B TARS2 FAAP100 TGIF1 ARSL PKD1 MLH1 ZNF808 NID1 USP54 DHX34 TRIM37 DNPEP	3.27e-04	1215	137	14	15146197
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	GRIN2D ECT2 ZP2 SHANK2 PKD1 RPUSD2 LTBP2	3.42e-04	329	137	7	17474147
Pubmed	Microarray-based mutation analysis of 183 Spanish families with Usher syndrome.	CDH23 USH2A	4.25e-04	8	137	2	19683999
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GPR39 ADRA1B MAST4 SHANK2 SLAIN1 FGFR3 USP54 KLK13	8.18e-08	179	136	8	815b959ce8721c5ded70c0ca6e318dafc691746e
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERBB2 METRNL GPR39 NLGN1 ITGB6 SHANK2 COBL USP54	1.05e-07	185	136	8	c82eab551f65ecebe6db908eda9f9eb3414693c7
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Lgi2_(Golgi_interneuron)--\|Cerebellum / BrainAtlas - Mouse McCarroll V32	GPR39 GDF3 ECT2 TMC3 SLCO4C1 NPC1L1	1.36e-07	77	136	6	afe990041849a68fd75e0c11b633a7b90fefade1
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Lgi2_(Golgi_interneuron)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	GPR39 GDF3 ECT2 TMC3 SLCO4C1 NPC1L1	1.36e-07	77	136	6	ec8f625cae561986ed27dfaefa8f822dd1c4fba1
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Lgi2_(Golgi_interneuron)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	GPR39 GDF3 ECT2 TMC3 SLCO4C1 NPC1L1	1.36e-07	77	136	6	af7e1e76db33b115238b6fc61fc0dd86aab8e49d
ToppCell	367C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	FBXW4 TBC1D22B CCNJ TARS2 PKD1 XCL2 DNPEP	1.33e-06	179	136	7	5aa8465e943b6b666c7f8b1937fcc3764bfe91f6
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	KDM5A DOCK10 DHRS13 SPATA31C1 MYO3A ARHGAP31 CDON	1.38e-06	180	136	7	886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8
ToppCell	Control-Epithelial_alveolar-AT_1-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	METRNL GPR39 NLGN1 ITGB6 SHANK2 COBL USP54	1.48e-06	182	136	7	a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NLGN1 ITGB6 SHANK2 ADAMTS17 SLAIN1 USP54 CDON	1.66e-06	185	136	7	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	METRNL GPR39 NLGN1 ITGB6 SHANK2 COBL USP54	1.66e-06	185	136	7	3937e026add96a396122139daf8011cfbc60e75c
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPR39 NLGN1 ITGB6 MYO3A SHANK2 COBL USP54	1.72e-06	186	136	7	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERBB2 GPR39 NLGN1 ITGB6 SHANK2 COBL USP54	1.72e-06	186	136	7	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	FN1 RYR2 ADRA1B ADAMTS17 ULK4 NID1 LTBP2	1.78e-06	187	136	7	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	TRPM7 CEP85L ARHGAP26 DOCK10 JMJD1C IGF2R PCNX1	1.84e-06	188	136	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GPR39 ITGB6 MAST4 SHANK2 SLAIN1 FGFR3 USP54	1.98e-06	190	136	7	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	GPR39 NLGN1 ITGB6 MAST4 SHANK2 SLCO4C1 USP54	2.05e-06	191	136	7	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GPR39 ITGB6 MAST4 SHANK2 COBL SLAIN1 USP54	2.05e-06	191	136	7	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	GPR39 ITGB6 MAST4 SHANK2 COBL SLAIN1 USP54	2.05e-06	191	136	7	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GPR39 ITGB6 MAST4 SHANK2 COBL SLAIN1 USP54	2.19e-06	193	136	7	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GPR39 NLGN1 SIM1 ITGB6 MAST4 SHANK2 COBL	2.27e-06	194	136	7	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KCNH8 CDH23 F8 RYR2 STRC DHX34	9.20e-06	158	136	6	7f5426585d0d299d2b48e5fcb349950feffdef33
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN1 RYR2 OTOGL LTBP2 USH2A UNC80	1.35e-05	169	136	6	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DHRS13 SKP2 PGAP6 ADGB AP1B1 RPUSD2	1.44e-05	171	136	6	bf475a69db04d4a886e442704955c6a96ff0de46
ToppCell	MS-CD8-proli_CD4\|MS / Condition, Cell_class and T cell subcluster	FBXL6 GYS1 SHPRH C12orf42 SLAIN1 USP54	1.49e-05	172	136	6	0b6dd257110b3f17fa71ab18a165b091a9d5ae9a
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	METRNL GPR39 NLGN1 ITGB6 SHANK2 USP54	1.59e-05	174	136	6	d0e3d15731de6c19c232e3aa492c39d8151cf4ed
ToppCell	Control-Epithelial_alveolar-AT_1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	METRNL GPR39 NLGN1 ITGB6 SHANK2 COBL	1.81e-05	178	136	6	aa7d43c655df493f1330a5001efaa484e4a19f69
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FN1 MYO3A ADRA1B IGF2R ADAMTS17 NID1	1.87e-05	179	136	6	b559f5a72cc9e3e35d05cb539b5c2e006e56e652
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	CATSPERD RYR2 ARSF LTBP2 FGFR3 USH2A	1.99e-05	181	136	6	c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPR39 NLGN1 ITGB6 SHANK2 COBL USP54	2.18e-05	184	136	6	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	GPR39 NLGN1 ITGB6 MAST4 SHANK2 SLCO4C1	2.18e-05	184	136	6	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NLGN1 ITGB6 SHANK2 ADAMTS17 SLAIN1 USP54	2.18e-05	184	136	6	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GPR39 ADRA1B MAST4 SHANK2 COBL USP54	2.18e-05	184	136	6	102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GPR39 ITGB6 MAST4 SHANK2 SLAIN1 USP54	2.32e-05	186	136	6	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NLGN1 ITGB6 MAST4 SHANK2 SLAIN1 USP54	2.32e-05	186	136	6	e83718fabb057100835d3357df407f283d23fe16
ToppCell	Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|World / Lineage, Cell type, age group and donor	GPR39 ITGB6 ADRA1B MAST4 SHANK2 USP54	2.39e-05	187	136	6	81cc8435b2704a9a8287b3f54acaae0f11dd4ac7
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	KCNH8 GPR39 FAT2 MAST4 SHANK2 FGFR3	2.39e-05	187	136	6	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	GPR39 ITGB6 MAST4 SHANK2 COBL USP54	2.46e-05	188	136	6	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NLGN1 ITGB6 MAST4 SHANK2 SLAIN1 USP54	2.46e-05	188	136	6	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	GPR39 ITGB6 MAST4 SHANK2 COBL USP54	2.46e-05	188	136	6	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ITGB6 MAST4 SHANK2 SLAIN1 FGFR3 USP54	2.69e-05	191	136	6	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GPR39 ITGB6 MAST4 SHANK2 COBL USP54	2.69e-05	191	136	6	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KCNH8 GPR39 ECT2 MYO3A SHANK2 SLAIN1	2.77e-05	192	136	6	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	GPR39 ITGB6 MAST4 SHANK2 COBL USP54	2.77e-05	192	136	6	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	GPR39 MAST4 SHANK2 COBL FGFR3 USP54	2.77e-05	192	136	6	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	GPR39 ITGB6 MAST4 SHANK2 COBL USP54	2.77e-05	192	136	6	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	IPF-Epithelial-Basal\|World / Disease state, Lineage and Cell class	GPR39 ITGB6 FAT2 MAST4 MID1 FGFR3	2.77e-05	192	136	6	9b91e0b162e6f3ce86dd15cc33c2e745d069581f
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN1 JMJD1C MAST4 SHANK2 SCMH1 TRAPPC9	2.77e-05	192	136	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DPYD ARHGAP26 JMJD1C CD163L1 PCNX1 TRAPPC9	2.85e-05	193	136	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	CATSPERD DRC1 ADGB FAM229B ULK4 CCDC17	2.85e-05	193	136	6	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MIER2 FN1 ARHGAP26 GDF3 ARHGAP31 HYAL2	2.94e-05	194	136	6	cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN1 ITGB6 MAST4 SHANK2 SCMH1 COBL	2.94e-05	194	136	6	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GPR39 ITGB6 MAST4 SHANK2 COBL USP54	2.94e-05	194	136	6	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	proximal-Hematologic-Natural_Killer_T-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZNF765 DOCK10 RPAP1 GYS1 XCL2 RPUSD2	3.02e-05	195	136	6	4d7c2c4d0130c2d46877ff6dd4584525d8f74daf
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NLGN1 SIM1 ITGB6 MAST4 SHANK2 COBL	3.02e-05	195	136	6	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	proximal-3-Hematologic-Natural_Killer_T\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZNF765 DOCK10 RPAP1 GYS1 XCL2 RPUSD2	3.02e-05	195	136	6	93093545bb23d2619ace029a52cffa1f673a0c2a
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GPR39 ITGB6 MAST4 SHANK2 COBL USP54	3.02e-05	195	136	6	9406866f99555198a9be311fbd65751b70f35446
ToppCell	proximal-Hematologic-Natural_Killer_T\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZNF765 DOCK10 RPAP1 GYS1 XCL2 RPUSD2	3.02e-05	195	136	6	3944e4800f5d904d4efa401ce8913ec0e0781211
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GPR39 NLGN1 SIM1 SHANK2 SLCO4C1 COBL	3.11e-05	196	136	6	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	CDH23 DRC1 MAST4 MID1 FGFR3 CDON	3.20e-05	197	136	6	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	CDH23 DRC1 MAST4 MID1 FGFR3 CDON	3.20e-05	197	136	6	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1B RYR2 SHANK2 KCND2 PKD1 UNC80	3.29e-05	198	136	6	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GPR39 ITGB6 MAST4 SHANK2 COBL USP54	3.39e-05	199	136	6	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GPR39 ITGB6 MAST4 SHANK2 COBL USP54	3.39e-05	199	136	6	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial\|10w / Sample Type, Dataset, Time_group, and Cell type.	FN1 SIM1 ARSL PDE8B NID1 LTBP2	3.48e-05	200	136	6	ff0b2675c68e9fc1fa16b3276431f199f3642eac
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell\|10w / Sample Type, Dataset, Time_group, and Cell type.	FN1 SIM1 ARSL PDE8B NID1 LTBP2	3.48e-05	200	136	6	07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NLGN1 SIM1 ITGB6 SHANK2 STRC	4.43e-05	127	136	5	5b0adbcafad31a6759c9bdce2f7f9591a8edc450
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPR39 NLGN1 ITGB6 SHANK2 USP54	4.96e-05	130	136	5	6434d9106ccb38786dad36fab80163dfc07b6eb7
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NLGN1 ITGB6 SHANK2 NPC1L1 SLAIN1	5.52e-05	133	136	5	5bf5e654653e2c340891f51e3f2a30441b7b6b2b
ToppCell	Control-Epithelial_alveolar-AT_1-AT2_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPR39 NLGN1 ITGB6 COBL USP54	7.54e-05	142	136	5	94e277f038f4006d99ff50222b0f5cf89bc3d46d
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Astrocyte\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	METRNL SETD6 CDH23 F8 CDON	7.54e-05	142	136	5	85e573616e54d41391b4ad8c3d38e4ca92112673
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2-Excitatory_Neuron.Slc17a7-Slc17a6.Fezf2-3110035E14Rik_(Layer_5,_Retrosplenial_cortex_(RSG)_and_Subiculum,_Tshz2+)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	KCNH8 ZP2 TMC3 HPX	7.80e-05	74	136	4	83b762542508f9d6407e4b0087d70bea81a8fc7d
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B SIM1 OTOGL USH2A UNC80	8.32e-05	145	136	5	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	OTOGL PDE8B NPC1L1 ULK4 LTBP2	1.04e-04	152	136	5	621e9b33cd3bb1c7b7d0633069f286b203e3d9c0
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B DRP2 F8 NID1 RNF208	1.14e-04	155	136	5	8fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	SETD6 CDH23 ZNF687 CDON	1.22e-04	83	136	4	7893ce9fbf34c6250dca9c265fe9b2d4cb889ade
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B VPREB3 RYR2 USH2A UNC80	1.32e-04	160	136	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B VPREB3 RYR2 USH2A UNC80	1.32e-04	160	136	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1B SIM1 OTOGL USH2A UNC80	1.40e-04	162	136	5	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ARHGAP26 TBC1D22B ARSF FAM106A XCL2	1.40e-04	162	136	5	4b9f80f701dcbb2508f497095cb8a7a2ca51cb5e
ToppCell	droplet-Liver-Hepatocytes-21m-Lymphocytic-NK/T\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPHS1 CATSPERD LAX1 SLAIN1 USH2A	1.40e-04	162	136	5	eb2900a250fb3e08e479c727c7d3200cbcf37fbc
ToppCell	droplet-Liver-Hepatocytes-21m-Lymphocytic-NK_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPHS1 CATSPERD LAX1 SLAIN1 USH2A	1.40e-04	162	136	5	1ef3084b5766641ec07c6f488c1756239cf3fd61
ToppCell	Ciliated_cells-B-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	CATSPERD ADGB FAM229B CCDC17 CPEB1	1.48e-04	164	136	5	fd30c55d0d75ef8b9396435d836187168095152b
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-GABAergic_neurons\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	KCNH8 ARSL COBL UNC80	1.53e-04	88	136	4	5582fd7bac60c690ecd1f2aff1d446ccb69f79b9
ToppCell	droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPHS1 HK2 TMC3 SHANK2 PDE8B	1.61e-04	167	136	5	3c06894fc6177f3c204094719904da42f08b9af8
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NPHS1 NLGN1 MYO3A SHANK2 HRH1	1.66e-04	168	136	5	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK10 ITGAE FAT2 ADAMTS17 PCNX1	1.71e-04	169	136	5	8caf7996796a2e2716e3855de855c903d6126bf2
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNH8 DOCK10 ADRA1B CD163L1 ADAMTS17	1.75e-04	170	136	5	36dbbdb13f69307afd2122ff051b2980850c1f00
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	METRNL SETD6 NLGN1 HMCN2 CDON	1.80e-04	171	136	5	82de2885c8ce4fb7776da6a0207b3355c0910121
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	METRNL SETD6 NLGN1 HMCN2 CDON	1.80e-04	171	136	5	09e653973962fb884878089d281f0947f7a285f6
ToppCell	ASK440-Epithelial-Transformed_epithelium\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	SHPRH ZNF808 SLAIN1 LTBP2 LRRC41	1.85e-04	172	136	5	df3800bcd9777d02900eba0cfc26ab73de8a1d95
ToppCell	droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GDF3 MAST4 ARHGAP31 NID1 TRIM37	1.85e-04	172	136	5	a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 ARHGAP26 F8 ARHGAP31 HYAL2	1.85e-04	172	136	5	c056d44e2e130ceccadfcdceb192a7f095d779c8
ToppCell	Control-Myeloid-MoAM2,_CCL18\|Control / Condition, Lineage and Cell class	FN1 METRNL CD163L1 HPX LTBP2	1.95e-04	174	136	5	4c64ff5666812fb4efa440ba4faeca51d916d68e
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPYD VPREB3 RYR2 USH2A UNC80	2.01e-04	175	136	5	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GDF3 MAST4 ARHGAP31 NID1 TRIM37	2.06e-04	176	136	5	3494ffa8555e6edf4b1250e10434bae9b73ec845
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	KCNH8 TRPM7 KDM5A PIAS1 EIF2A	2.06e-04	176	136	5	3c76a5c4ca2b378667cb155fbb9675519572b35d
ToppCell	droplet-Liver-Npc-18m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GDF3 MAST4 ARHGAP31 NID1 TRIM37	2.06e-04	176	136	5	d43f6b7828b98e1dab7b726a5f99499d65a7db80
ToppCell	Control-Myeloid-MoAM2,_CCL18\|Myeloid / Condition, Lineage and Cell class	FN1 METRNL CD163L1 HPX LTBP2	2.11e-04	177	136	5	470f54fe2b21c7350ea471e02039461a3808f700
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPR39 NLGN1 ITGB6 SHANK2 COBL	2.11e-04	177	136	5	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	Control-Epithelial_alveolar-AT_1-AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	METRNL NLGN1 ITGB6 SHANK2 COBL	2.17e-04	178	136	5	1817bc520f3d23da8c0fa09bba50ae703a820cb1
Drug	Cotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A	MIER2 KDM5A ARHGAP26 VN1R1 RYR2 SHANK2 HPX PCNX1 LRRC41	2.66e-06	199	133	9	1511_UP
Drug	Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; HL60; HT_HG-U133A	FBXW4 NLGN1 PTGER1 FAAP100 ITGB6 FBXL6 CRYGC RPAP1 DHX34	2.77e-06	200	133	9	2988_DN
Drug	CAS 298-57-7	CACNA1B PTGER1 RYR2 RIF1 PKD1 HRH1	4.38e-06	73	133	6	CID000002761
Drug	Fillalbin [4540-25-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	TBC1D22B SKP2 FBXL6 MAST4 AP2B1 FGD1 DHX34 DNPEP	1.97e-05	195	133	8	2813_DN
Drug	Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A	DOCK10 VN1R1 FAAP100 RIF1 HPX FGD1 TOP3A DNPEP	2.12e-05	197	133	8	7344_UP
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HG-U133A	FN1 GDF3 SKP2 MAST4 PCNX1 FGFR3 DHX34 TRAPPC9	2.20e-05	198	133	8	421_DN
Drug	Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A	FN1 NPEPL1 SKP2 FAAP100 LAX1 SHANK2 DHX34 DNPEP	2.20e-05	198	133	8	4550_DN
Drug	Epiandrosterone [481-29-8]; Up 200; 13.8uM; MCF7; HT_HG-U133A	GPR39 DOCK10 VN1R1 RPAP1 FGD1 NID1 KLK13 TOP3A	2.28e-05	199	133	8	5687_UP
Drug	Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; HL60; HT_HG-U133A	ERBB2 PTGER1 NPEPL1 SKP2 FBXL6 CRYGC RPUSD2 LTBP2	2.28e-05	199	133	8	2987_DN
Drug	Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; MCF7; HT_HG-U133A	MIER2 ARHGAP26 VPREB3 CRYGC HPX FGD1 TRAPPC9 TOP3A	2.28e-05	199	133	8	4728_UP
Drug	CAF protocol	ERBB2 SKP2	3.39e-05	2	133	2	ctd:C035000
Drug	loperamide	CACNA1B GRIN2D RYR2 PKD1 HRH1 TOP3A	3.56e-05	105	133	6	CID000003954
Disease	autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology)	STRC STRCP1	1.93e-05	2	130	2	DOID:0110471 (implicated_via_orthology)
Disease	Weill-Marchesani syndrome	ADAMTS17 LTBP2	1.15e-04	4	130	2	cv:C0265313
Disease	Weill-Marchesani syndrome (is_implicated_in)	ADAMTS17 LTBP2	1.15e-04	4	130	2	DOID:0050475 (is_implicated_in)
Disease	chemokine (C-X-C motif) ligand 1 measurement	PF4V1 JMJD1C	1.91e-04	5	130	2	EFO_0008083
Disease	gamma-aminobutyric acid receptor-associated protein-like 1 measurement	HRH1 DHX34	1.91e-04	5	130	2	EFO_0801613
Disease	bone measurement, fat body mass, lean body mass	HRH1 DHX34	3.99e-04	7	130	2	EFO_0004512, EFO_0004995, EFO_0005409
Disease	Nonsyndromic Deafness	CDH23 MYO3A OTOGL STRC	4.60e-04	81	130	4	C3711374
Disease	Autism Spectrum Disorders	DPYD RYR2 USH2A UNC80	5.53e-04	85	130	4	C1510586
Disease	RS-6-hydroxywarfarin measurement	ARHGAP26 RTN4R RYR2 SHANK2 TRAPPC9	6.33e-04	155	130	5	EFO_0803328
Disease	Autoimmune Diseases	F8 ITGB6 HPX	8.46e-04	42	130	3	C0004364
Disease	hearing impairment	CDH23 MYO3A FGFR3 USH2A	9.44e-04	98	130	4	C1384666
Disease	Mammary Ductal Carcinoma	ERBB2 PTGER1	1.03e-03	11	130	2	C0021367
Disease	Invasive Ductal Breast Carcinoma	ERBB2 PTGER1	1.03e-03	11	130	2	C1134719
Disease	decanoylcarnitine measurement	HRH1 DHX34	1.24e-03	12	130	2	EFO_0021039
Disease	immature platelet count	DOCK10 GCSAML JMJD1C AP2B1	1.26e-03	106	130	4	EFO_0803544
Disease	urinary bladder cancer (is_marker_for)	ERBB2 FN1 MLH1 FGFR3	1.31e-03	107	130	4	DOID:11054 (is_marker_for)
Disease	pallidum volume change measurement	KCNH8 TRAPPC9	1.46e-03	13	130	2	EFO_0021494
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	CDH23 MYO3A STRC	1.49e-03	51	130	3	cv:CN043650
Disease	response to cisplatin, platinum measurement	ECT2 SPATA31C1 ADRA1B	1.67e-03	53	130	3	EFO_0010154, GO_0072718
Disease	Kartagener syndrome (implicated_via_orthology)	DRC1 AP1B1	1.69e-03	14	130	2	DOID:0050144 (implicated_via_orthology)
Disease	rostral middle frontal gyrus volume measurement	ITGB6 ADGB	1.69e-03	14	130	2	EFO_0010328
Disease	alcohol use disorder (implicated_via_orthology)	ERBB2 KDM5A JMJD1C RYR2 ADRA1B	1.76e-03	195	130	5	DOID:1574 (implicated_via_orthology)
Disease	immature platelet measurement	DOCK10 GCSAML JMJD1C AP2B1	1.93e-03	119	130	4	EFO_0803541
Disease	Alobar Holoprosencephaly	TGIF1 CDON	1.95e-03	15	130	2	C0431363
Disease	Lobar Holoprosencephaly	TGIF1 CDON	2.22e-03	16	130	2	C0431362
Disease	Semilobar Holoprosencephaly	TGIF1 CDON	2.22e-03	16	130	2	C0751617
Disease	Holoprosencephaly	TGIF1 CDON	2.51e-03	17	130	2	C0079541
Disease	1-Methylhistidine measurement	KCND2 OTOGL	2.51e-03	17	130	2	EFO_0021543
Disease	renal cell carcinoma (is_marker_for)	ERBB2 FN1 SKP2 MLH1	2.52e-03	128	130	4	DOID:4450 (is_marker_for)
Disease	laryngeal squamous cell carcinoma (is_marker_for)	ERBB2 MLH1	3.14e-03	19	130	2	DOID:2876 (is_marker_for)
Disease	kidney failure (biomarker_via_orthology)	NPHS1 SLCO4C1	3.14e-03	19	130	2	DOID:1074 (biomarker_via_orthology)
Disease	pulse pressure measurement	FN1 TRPM7 KDM5A LYPLAL1 SETD6 ARHGAP26 TGIF1 ADRA1B PKD1 HRH1 ULK4 LTBP2 DHX34 TRAPPC9	3.37e-03	1392	130	14	EFO_0005763
Disease	Vertigo	CDH23 MAST4 KCND2 OTOGL	3.39e-03	139	130	4	HP_0002321
Disease	ascending aortic diameter	JMJD1C RYR2 ULK4 TRAPPC9	3.48e-03	140	130	4	EFO_0021787
Disease	body weight	CACNA1B DPYD COPB1 SETD6 NLGN1 SIM1 SPATA31C1 MAST4 SCMH1 PKD1 ADAMTS17 ULK4 LTBP2	3.82e-03	1261	130	13	EFO_0004338

Protein segments in the cluster

Peptide	Gene	Start	Entry
VRLTQHISAASLCSP	ARSF	66	P54793
TRQLRRCPGSHCLTI	FAM229B	41	Q4G0N7
LTLIDTNRSRACHPC	ERBB2	181	P04626
RSSALLATHTQRFCI	CCDC17	21	Q96LX7
CERVTPRLSHANSAV	AP2B1	241	P63010
LTQHISAASLCTPSR	ARSL	76	P51690
PLVTAQLCRSRTVRT	CATSPERD	16	Q86XM0
TELVLRRISASCQHP	DNPEP	326	Q9ULA0
RVLVQTGHRSLTSCI	ACAD8	21	Q9UKU7
HICSHPVLVTRSRSC	ADGB	451	Q8N7X0
LPLSTNRLHCLRNTS	FAM106A	11	Q4KMX7
SNRFTLCPSARHLAV	CCNJ	51	Q5T5M9
VILSVACNRHLRTPT	ADRA1B	66	P35368
GLSDSVQSCRIIPHT	CRYGA	71	P11844
LALNPRTQTHATLCS	DPYD	16	Q12882
CERVTPRLSHANSAV	AP1B1	241	Q10567
SHPALCSLNLRGTRV	FBXL6	471	Q8N531
RVCNVTRRPASHQTF	AGO3	281	Q9H9G7
SLICSAHRQPRLVGA	CD163L1	786	Q9NR16
SISTLAQRPRGTHLC	CACNA1B	2021	Q00975
VTATDQCPILSHRLT	CDH23	1711	Q9H251
QCPILSHRLTSTTTV	CDH23	1716	Q9H251
TCLLVTDPRSQHTVR	ADAMTS17	446	Q8TE56
CPANLLSSHRSLVQR	ECT2	661	Q9H8V3
SHNNRLTPGTTCRVS	KLK13	146	Q9UKR3
TSSATLHCRARGVPN	NPHS1	856	O60500
LPLSTNRLHCLRNTS	FAM106C	11	P0CH98
CVRRNPSASTFLHLS	HYAL2	376	Q12891
PRQSLTPTHVTAACA	MAP3K10	806	Q02779
VNVPSHRGLTCNRSS	GPR39	181	O43194
SQPTFTEHLLRAVCT	HHLA3	41	Q9XRX5
TRRLTVHFNPPSSCV	MAPK8IP1	596	Q9UQF2
SCSVHSALPFRLQLR	HMCN2	446	Q8NDA2
VTTFRNDCRSPTHLT	JMJD1C	1176	Q15652
PSRSVTHVSLVALCF	KIAA1109	1746	Q2LD37
HLPLSQRACARVITS	DDX60	321	Q8IY21
HLPLSQRACSRVITC	DDX60L	306	Q5H9U9
RCSLHASLLVVTLNP	GDF3	226	Q9NR23
THRICQIVSTRSASL	HK2	371	P52789
ICIQVLVRRPHSLSS	ITGAE	106	P38570
CVKTTSQVRPRHITS	PF4V1	46	P10720
VPCRRSSTSQISLRN	PCNX1	2146	Q96RV3
LSILTPRHHLQRSCS	FAT2	3756	Q9NYQ8
SFSVTVNIPHCERRS	ITGB6	416	P18564
LSHCTGSLSRPVLTQ	IGLV11-55	11	A0A075B6I3
LFHSTPRVLCSTLAN	OR51T1	266	Q8NGJ9
VAALPCRVSRHNSPS	NPEPL1	76	Q8NDH3
CVGVTRPLLHAARVS	PTGER1	136	P34995
CRSIRATNPSEHTVI	PDE8B	196	O95263
LSPSITQRAAECVHR	NID1	126	P14543
QLLVRTLHSCSVRFP	COPB1	381	P53618
LQSLSDSRHSRTCSP	DDIAS	736	Q8IXT1
IRCVERTPLSNSRSS	KCND2	561	Q9NZV8
NLTPSAHCINVRASR	LAX1	166	Q8IWV1
DCLTRSHSIPQANRS	F8	1391	P00451
NTFSPARHLTVCIRS	METRNL	96	Q641Q3
AVAALTACRPRSVTI	PGAP6	296	Q9HCN3
RCSPQRTTTNDLTHA	NLGN1	751	Q8N2Q7
ICSVVSLSASPRTHE	FAAP100	401	Q0VG06
HRLSSSLQIKPCSQA	DRC1	556	Q96MC2
VCLQARPRHSVASLE	KDM5A	961	P29375
SCSRVRVPAAATLAV	NPC1L1	171	Q9UHC9
ALLRTSVSRPCSCTH	GCSAML	111	Q5JQS6
IAQCTSSHPIIRQIR	CHCHD5	41	Q9BSY4
QCKRRTILTTSHLFP	DOCK10	1996	Q96BY6
RVPHSRNSITLTNLT	FN1	1496	P02751
VVLHCSAQPVTTRIS	CDON	46	Q4KMG0
LSTQDRPAAIHRSSC	COBL	961	O75128
RPAAIHRSSCFSLVQ	COBL	966	O75128
ALTSQLRTIGPSCLH	CEP85L	191	Q5SZL2
RTVRLHPTATASSQL	LTBP2	296	Q14767
RRQRACLHAFPLTST	FBXW4	366	P57775
RCIVSPAGRHSASLI	LYPLAL1	11	Q5VWZ2
PLLHTSRSFSCLNRS	MAST4	1276	O15021
SVRSLLQACSHDPLS	CPEB1	371	Q9BZB8
IRSCCLIPQTVSHRL	CRYGC	76	P07315
CQHRELINRSLPSFS	HRH1	221	P35367
HILTATCAPRLRVNN	EIF2A	371	Q9BY44
RVLCHFSVRVTDAPS	FGFR3	116	P22607
CRARRLPVATIFTTH	GYS1	191	P13807
HVACTQPRRIACISL	DHX34	206	Q14147
RLSTVTLATVDCQPH	ERVFC1	46	P60507
CIARTVSSPNQHLLR	RYR2	736	Q92736
LRSTCPHPQVRAAVT	DRP2	31	Q13474
APSRVVVVASAAHCR	DHRS13	161	Q6UX07
SLGRQSPRVVSCLEH	MIER2	6	Q8N344
SRSVFCLPRSSVHTS	OTOGL	1236	Q3ZCN5
TSPRQAVCLTRHLTA	PKD1	3036	P98161
RCSPHLVLSALTSDN	HPX	256	P02790
TTRIHLVCSRGRLNS	IGF2R	886	P11717
QSSVVRCRPLTGRTH	RPUSD2	356	Q8IZ73
HVPAASFRACRNLTI	RTN4R	71	Q9BZR6
QACRLHTAVVSTPPR	TARS2	16	Q9BW92
TPVSIRSNRSACVLR	USH2A	5111	O75445
RISRRTHLCSAATSS	TRIM37	596	O94972
CASTSDLHRNRSRTP	TMC3	826	Q7Z5M5
LSRNSSDTCLRNPLH	TBC1D22B	136	Q9NU19
PLLHSSRHVRQLTIC	LRRC41	156	Q15345
RRCSIVRSHSSNSSP	RIF1	2221	Q5UIP0
SPACSQHTPQRRRSI	FGD1	796	P98174
CSERPLTLFHTVQST	ARHGAP26	596	Q9UNA1
HSQTFSSIRECRRSP	SLAIN1	351	Q8ND83
ATIVHNSRSSRPHCI	SIM1	311	P81133
VVPRAALLSQHTCSI	SETD6	91	Q8TBK2
NVIESATVCHLRPAR	SHPRH	1221	Q149N8
RLTIPCRALTCSHLQ	PIAS1	341	O75925
LVSQRHLVSQCPTGR	SPATA31C1	66	P0DKV0
TAACTPRRRIINLTS	MLH1	491	P40692
RCQSSVPALAHPTRL	STRC	606	Q7RTU9
STSQRHRPLLSSCGL	SCMH1	521	Q96GD3
CSTATSHRSLSPQLL	SHANK2	436	Q9UPX8
PRPTRRFHTVCSQAL	C12orf42	336	Q96LP6
RFHTVCSQALSRPVV	C12orf42	341	Q96LP6
SQTLRGHVLCRTTLR	CDK5RAP1	581	Q96SZ6
LQINCSHFTTIARPT	SKP2	386	Q13309
LARPSVICHTTVTAL	TGIF1	296	Q15583
GTRLLVVSTQLSHCR	PEX11G	46	Q96HA9
VSHRRTCVSLTTQRL	XCL2	26	Q9UBD3
HSRASLVIPPCQRSR	UNC80	311	Q8N2C7
VTNLASRRLSVSPSC	UNC80	1781	Q8N2C7
NVTQRRPRVLSCLHS	RNF208	151	Q9H0X6
AIPSRTIANTTCHLP	SLC5A10	231	A0PJK1
TPITVSILRCVNHRQ	SLCO4C1	596	Q6ZQN7
CPTCRHVITLSQRGL	MID1	56	O15344
LSCRPSQEARATHTI	VN1R1	261	Q9GZP7
STSQRISCRPQIHIS	ZNF808	191	Q8N4W9
LRVSAVISTNSTPCR	ARHGAP31	496	Q2M1Z3
THCSPARASLLASQA	RPAP1	1061	Q9BWH6
ARFSEITPHAVRTAC	TOP3A	176	Q13472
LPVDSTQARRCQHSR	ZNF786	306	Q8N393
AQLSCTLSPQHVTIR	VPREB3	36	Q9UKI3
ILRHTAIICTSRSLN	TRAPPC8	1066	Q9Y2L5
SFCSAPSLRRHVRVN	ZNF687	1001	Q8N1G0
TAQRISCRPETHISN	ZNF765	176	Q7L2R6
RCQSSVPALAHPTRL	STRCP1	606	A6NGW2
RLQISTSLPRSAHSL	TRAPPC9	696	Q96Q05
TRVSTLPATSTRQCH	TRAPPC9	891	Q96Q05
ICSRHRVTSAGLTLQ	UNQ5830/PRO19650/PRO19816	61	Q6UY13
SVTCPVSSRHRRATG	ZP2	631	Q05996
VSSRLRPFVAHTCTQ	TRPM7	726	Q96QT4
ITAVSALCRITRHSP	ULK4	666	Q96C45
ALCRITRHSPTAFQN	ULK4	671	Q96C45
HEARTVRTSQATPCR	USP54	1381	Q70EL1
HSTSVCPSRESLQTR	KCNH8	911	Q96L42
RTLSRCSLHSASPAS	KIAA1522	316	Q9P206
TSHCVVTRGETIIRP	MYO3A	651	Q8NEV4
IRDSVPCRSQLNRTH	GRIN2D	456	O15399